Results: All patients were able to complete radiotherapy. All but 4 patients received all 4 cycles of gemcitabine. Of the 47 patients who underwent post-therapy cystoscopic evaluation, 88% achieved a complete tumor response. The median follow-up was 36 months, and, at last follow-up, 36 patients were alive. Of these, 32 patients had an intact, functional… (More)
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.